Pharma Focus Asia

SCHOTT Pharma Plans to Open New Production Facility in Jagodina, Serbia

Introduction:

SCHOTT Pharma is investing a multimillion-euro investment to open a state-of-the-art production facility for pharmaceutical drug containment solutions and delivery systems in Jagodina, Serbia.

Features:

This investment aims to improve manufacturing flexibility to cater to customer needs in the region and meet the growing need for pharmaceutical drug containment solutions and delivery systems.

The site will focus on manufacturing ampoules designed for the storage of injectable medications such as painkillers, anti-inflammatory drugs, and anaesthetics.

During the initial phase, the facility will generate 130 new job opportunities, with plans for an expansion phase that will see an additional 350 positions created.

This initiative strengthens foothold in Europe, enhancing competitive edge and bolstering manufacturing flexibility to better serve customers across the region.

The new facility in Jagodina will create over 100 positions, with production expected to commence in 2024. 

Specifications:

Name    SCHOTT Pharma
Type      New Construction
Year       2024

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024